Healthcare -
Biotechnology - NASDAQ - US
$ 3.34
2.77 %
$ 213 M
Market Cap
-2.9
P/E
LRMR - CASH & EQUIVALENTS
Cash & Equivalents LRMR - Larimar Therapeutics, Inc.
26.7 M
LAST VALUE
-38.23%
2 YEAR CAGR
-11.52%
5 YEAR CAGR
-2.80%
10 YEAR CAGR